Compound: Gepotidacin
SMILES: O=c1n2c3n(c(=O)ccc3nc1)C[C@H]2CN4CCC(NCc5ncc6OCCCc6c5)CC4
InChIKey: PZFAZQUREQIODZ-LJQANCHMSA-N
Synonyms: Gepotidacin, 1075236-89-3, GSK-2140944, Gepotidacina, Gepotidacine, DVF0PR037D, DTXSID501028208, (3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione, 3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-((4-(((3,4-dihydro-2H-pyrano(2,3-C)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-, (2R)-, (2R)-2-[[4-[[(3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione, gepotidacinum, (2R)-2-((4-(((3,4-Dihydro-2H-pyrano(2,3-c)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione, (3R)-3-((4-(3,4-dihydro-2H-pyrano(2,3-c)pyridin-6-ylmethylamino)piperidin-1-yl)methyl)-1,4,7-triazatricyclo(6.3.1.04,12)dodeca-6,8(12),9-triene-5,11-dione, 3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-[[4-[[(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-, (2R)-, RefChem:639850, DTXCID501513790, (3R)-3-((4-(((2H,3H,4H-pyrano(2,3-c)pyridin-6-yl)methyl)amino)piperidin-1-yl)methyl)-1,4,7-triazatricyclo(6.3.1.0^(4,12))dodeca-6,8(12),9-triene-5,11-dione, GSK2140944, GSK 2140944, Blujepa, (R)-2-((4-(((3,4-Dihydro-2H-Pyrano[2,3-C]Pyridin-6-Yl)Methyl)Amino)Piperidin-1-Yl)Methyl)-1,2-Dihydro-3H,8H-2A,5,8A-Triazaacenaphthylene-3,8-Dione, (2R)-2-[(4-{[(3,4-dihydro-2H-pyrano[2,3-c]pyridin- 6-yl)methyl]amino}piperidin-1-yl)methyl]-1,2-dihydro- 3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione, (3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione, Gepotidacin [USAN:INN], UNII-DVF0PR037D, JHN, Gepotidacin [INN], Gepotidacin (USAN/INN), GEPOTIDACIN [USAN], GEPOTIDACIN [WHO-DD], orb1709615, SCHEMBL3332319, CHEMBL3317856, SCHEMBL29379990, GTPL10817, YQF2539, C24H28N6O3, GLXC-21974, ATB23689, EX-A7794, BDBM50050549, GSK 2140944E, MFCD27987926, AKOS032946511, CS-6531, DB12134, EBC-111025, T11391L, AC-38196, BP-44436, DA-73703, HY-16742, MS-28128, SY038432, NS00073409, D10878, G14345, Q19597285, (3R)-3-({4-[({2H,3H,4H-pyrano[2,3-c]pyridin-6-yl}methyl)amino]piperidin-1-yl}methyl)-1,4,7-triazatricyclo[6.3.1.0,4,12]dodeca-6,8(12),9-triene-5,11-dione, (3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)-1-piperidyl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione, (R)-2-[[4-[[[3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-yl]methyl]amino]piperidin-1-yl]methyl]-1,2-dihydro-2a,5,8a-triazaacenaphthylene-3,8-dione
Theoretical properties:
molecular_formula: C24H28N6O3
molecular_weight: 448.5 g/mol
exact_mass: 448.22228878 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 7
rotatable_bond_count: 5
heavy_atom_count: 33
topological_polar_surface_area: 90.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
chebi: A first-in-class triazaacenaphthylene antibiotic acting as topoisomerase II inhibitor and indicated for the treatment of female patients with uncomplicated urinary tract infections caused by susceptible microorganisms.
chembl: GEPOTIDACIN is a small molecule listed in the ChEMBL database and has reached clinical trial phase 3.0.
wikipedia: Gepotidacin, sold under the brand name Blujepa, is an antibiotic medication used for the treatment of urinary tract infection or uncomplicated urogenital gonorrhea. Gepotidacin is a triazaacenaphthylene bacterial type II topoisomerase inhibitor. It is used as the salt gepotidacin mesylate, and is taken by mouth.
Gepotidacin was approved for medical use in the United States in March 2025. Gepotidacin is a first-in-class triazaacenaphthylene antibiotic. It is the first triazaacenaphthylene antibiotic to be approved in the US.